Market Insights Health OTC Pharmaceuticals

Analgesics - Burundi

Burundi

In Burundi, the revenue in the Analgesics market is estimated to reach US$1.11m in 2024.
It is projected to experience an annual growth rate of 13.60% (CAGR 2024-2029).
When compared globally, the in the United States generates the highest revenue with US$7,243.00m in 2024.
Looking at the per person figures, in 2024, each individual in Burundi generates US$0.08 in revenue.
Due to limited access to healthcare facilities, the demand for over-the-counter analgesics is high in Burundi.

Key regions: Brazil, Europe, Germany, Canada, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Analgesics market in Burundi is experiencing significant growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Analgesics market in Burundi are shifting towards more natural and organic products. Consumers are becoming increasingly conscious about the ingredients used in analgesic products and are opting for those that are free from harmful chemicals and additives. This preference for natural products is driven by a growing awareness of the potential side effects of synthetic analgesics and a desire for safer alternatives.Trends in the market include the rising demand for over-the-counter (OTC) analgesics. As the healthcare system in Burundi continues to face challenges, consumers are turning to self-medication for minor ailments and pain relief. This has led to an increase in the sales of OTC analgesics, which are easily accessible and affordable.Another trend in the market is the growing popularity of online retail channels. With the increasing penetration of smartphones and internet access in Burundi, more consumers are shopping online for their analgesic needs. Online platforms offer convenience, a wide range of products, and competitive prices, making them an attractive option for consumers.Local special circumstances in Burundi also contribute to the development of the Analgesics market. The country has a young and growing population, which increases the overall demand for healthcare products, including analgesics. Additionally, the prevalence of certain health conditions, such as chronic pain and musculoskeletal disorders, further drives the demand for analgesics in the market.Underlying macroeconomic factors also play a role in the growth of the Analgesics market in Burundi. The country has been experiencing steady economic growth, which has resulted in an increase in disposable income among consumers. This allows them to afford analgesic products and invest in their health and well-being. Furthermore, the government's efforts to improve healthcare infrastructure and access to healthcare services have also contributed to the growth of the market.In conclusion, the Analgesics market in Burundi is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural and organic products, the demand for OTC analgesics, the popularity of online retail channels, the young and growing population, and the improving economic conditions in the country are all contributing to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.